{"id":329794,"date":"2021-03-16T12:38:02","date_gmt":"2021-03-16T11:38:02","guid":{"rendered":"https:\/\/medizinonline.com\/ginecologista-e-oncologista-falando-sobre-cancro-nos-ovarios\/"},"modified":"2021-03-16T12:38:02","modified_gmt":"2021-03-16T11:38:02","slug":"ginecologista-e-oncologista-falando-sobre-cancro-nos-ovarios","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/pt-pt\/ginecologista-e-oncologista-falando-sobre-cancro-nos-ovarios\/","title":{"rendered":"Ginecologista e oncologista falando sobre cancro nos ov\u00e1rios"},"content":{"rendered":"<p>Embora o progn\u00f3stico dos doentes com cancro nos ov\u00e1rios tenha melhorado nos \u00faltimos anos, ainda \u00e9 o tumor ginecol\u00f3gico mais mortal [1, 2]. Na entrevista em v\u00eddeo, o ginecologista Prof. Dr. med. Andreas G\u00fcnthert e o oncologista Dr. med. D\u00e9sir\u00e9e Gassmann fazem a sua avalia\u00e7\u00e3o da situa\u00e7\u00e3o actual dos doentes com cancro dos ov\u00e1rios e tamb\u00e9m esclarecem os efeitos da pandemia de Covid-19.<\/p>\n<p> <!--more--> <\/p>\n<p>Em conversa: Prof. Dr. med. Andreas G\u00fcnthert, especialista em ginecologia e obstetr\u00edcia, e Dr. med. D\u00e9sir\u00e9e Gassmann, especialista em medicina interna geral e especialista em oncologia m\u00e9dica do gyn-zentrum Luzern (www.gyn-zentrum.ch)<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><iframe frameborder=\"0\" height=\"360\" data-src=\"https:\/\/player.vimeo.com\/video\/524236915\" width=\"640\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" data-load-mode=\"1\"><\/iframe><\/p>\n<p>Experi\u00eancia com doentes com cancro nos ov\u00e1rios durante a pandemia de Covid-19<\/p>\n<p><iframe frameborder=\"0\" height=\"360\" data-src=\"https:\/\/player.vimeo.com\/video\/524237598\" width=\"640\" src=\"data:image\/svg+xml;base64,PHN2ZyB3aWR0aD0iMSIgaGVpZ2h0PSIxIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciPjwvc3ZnPg==\" class=\"lazyload\" data-load-mode=\"1\"><\/iframe><\/p>\n<p>As entrevistas reflectem as opini\u00f5es pessoais e independentes do Prof. G\u00fcnthert e do Dr. Gassmann. A GlaxoSmithKline AG n\u00e3o tem qualquer influ\u00eancia sobre o conte\u00fado.<\/p>\n<p>Respons\u00e1vel pelo conte\u00fado e financiado pela GlaxoSmithKline AG, Talstr. 3 &#8211; 5, 3053 M\u00fcnchenbuchsee.<\/p>\n<p>As marcas comerciais s\u00e3o propriedade dos seus respectivos propriet\u00e1rios. \u00a92020 Grupo de empresas GSK ou o seu licenciador.<\/p>\n<p><a href=\"https:\/\/assets.medizinonline.com\/sites\/default\/files\/201210_zejula_kurz-fi_d_10205.pdf\" target=\"_blank\" rel=\"noopener\">Informa\u00e7\u00e3o sobre temas curtos Zejula<\/a><\/p>\n<p>PM-CH-NRP-ADVR-210013-02\/2021<\/p>\n<p><strong>Literatura<\/strong><\/p>\n<p>1. Wu, J., et al, Improved survival in ovarian cancer, with widening survival gaps of races and socioeconomic status: a period analysis, 1983-2012. J Cancer, 2018. 9(19): p. 3548-3556.<\/p>\n<p>2 Buechel, M., et al, Tratamento de doentes com cancro epitelial recorrente dos ov\u00e1rios para os quais a platina ainda \u00e9 uma op\u00e7\u00e3o. Ann Oncol, 2019. 30(5): p. 721-732.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Embora o progn\u00f3stico dos doentes com cancro nos ov\u00e1rios tenha melhorado nos \u00faltimos anos, ainda \u00e9 o tumor ginecol\u00f3gico mais mortal [1, 2]. Na entrevista em v\u00eddeo, o ginecologista Prof.&hellip;<\/p>\n","protected":false},"author":12,"featured_media":104146,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Gest\u00e3o da terapia interdisciplinar","footnotes":""},"category":[11419,11379,11551],"tags":[],"powerkit_post_featured":[],"class_list":["post-329794","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ginecologia-pt-pt","category-oncologia-pt-pt","category-rx-pt","pmpro-has-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-28 01:48:55","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"pt_PT","wpml_translations":{"es_ES":{"locale":"es_ES","id":329770,"slug":"un-ginecologo-y-un-oncologo-hablan-sobre-el-cancer-de-ovario","post_title":"Un ginec\u00f3logo y un onc\u00f3logo hablan sobre el c\u00e1ncer de ovario","href":"https:\/\/medizinonline.com\/es\/un-ginecologo-y-un-oncologo-hablan-sobre-el-cancer-de-ovario\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/329794","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=329794"}],"version-history":[{"count":0,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/posts\/329794\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media\/104146"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=329794"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/category?post=329794"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/tags?post=329794"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/pt-pt\/wp-json\/wp\/v2\/powerkit_post_featured?post=329794"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}